Coding Analysis for Labs (CAL) Tracking Sheet

Blood Glucose Testing (Revision of ICD-9-CM Codes for Osteomyelitis)

CAG-00183N

Issue

There is a mismatch between the listed codes and the code description of osteomyelitis in the blood glucose national coverage determination (NCD). The NCD includes the coding range 730.07-730.27 and the description “osteomyelitis of tarsal bones.” The fifth digit of the codes in this range indicates location of the osteomyelitis and the codes listed include unspecified, shoulder, upper arm, forearm, hand, pelvic region and thigh, lower leg, ankle and foot, other sites and multiple sites. The Centers for Medicare and Medicaid Services (CMS) believes that osteomyelitis of the tarsal bones should be coded as 730.07, 730.17, and 730.27 to be consistent with the original intent of the NCD. Therefore, CMS proposes changing the codes for osteomyelitis of the tarsal bones to 730.07, 730.17 and 730.27.

CIM citation: Program Memorandum AB-02-110M

National Coverage Determinations

Benefit Category

Diagnostic Laboratory Tests

Requestor Information

Requestor Name Requestor Letter
Internally generated N/A
N/A

Important Dates

Formal Request Accepted and Review Initiated
02/21/2003
Expected CAL Completion Date
05/21/2003
Public Comment Period
03/21/2003 - 04/21/2003
Proposed Decision Memo Due Date
Proposed Decision Memo Released
Proposed Decision Memo Public Comment Period
Decision Memo Released
05/16/2003

Contacts

Lead Analysts
Jackie Sheridan-Moore
Lead Medical Officers

Medicare Benefit Category Determination Date

Actions Taken

February 21, 2003

Formal request accepted by CMS.

May 16, 2003

Coverage Decision Memorandum Released

June 6, 2003

CMS issues instructions implementing this NCD